Cargando…
Metabolic network as an objective biomarker in monitoring deep brain stimulation for Parkinson’s disease: a longitudinal study
BACKGROUND: With the advance of subthalamic nucleus (STN) deep brain stimulation (DBS) in the treatment of Parkinson’s disease (PD), it is desired to identify objective criteria for the monitoring of the therapy outcome. This paper explores the feasibility of metabolic network derived from positron...
Autores principales: | Ge, Jingjie, Wang, Min, Lin, Wei, Wu, Ping, Guan, Yihui, Zhang, Huiwei, Huang, Zhemin, Yang, Likun, Zuo, Chuantao, Jiang, Jiehui, Rominger, Axel, Shi, Kuangyu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7596139/ https://www.ncbi.nlm.nih.gov/pubmed/33119814 http://dx.doi.org/10.1186/s13550-020-00722-1 |
Ejemplares similares
-
Individual brain metabolic connectome indicator based on Kullback-Leibler Divergence Similarity Estimation predicts progression from mild cognitive impairment to Alzheimer’s dementia
por: Wang, Min, et al.
Publicado: (2020) -
Use of Overlapping Group LASSO Sparse Deep Belief Network to Discriminate Parkinson's Disease and Normal Control
por: Shen, Ting, et al.
Publicado: (2019) -
Dopamine transporter changes after unilateral deep brain stimulation in progressive Parkinson’s disease: a case report
por: Zhang, Huiwei, et al.
Publicado: (2014) -
Brain Network and Abnormal Hemispheric Asymmetry Analyses to Explore the Marginal Differences in Glucose Metabolic Distributions Among Alzheimer's Disease, Parkinson's Disease Dementia, and Lewy Body Dementia
por: Chen, Danyan, et al.
Publicado: (2019) -
Glucose Metabolic Brain Network Differences between Chinese Patients with Lewy Body Dementia and Healthy Control
por: Chen, Danyan, et al.
Publicado: (2018)